You are here

R&D

Big Pharma’s R&D spending flatlined in 2022: What it means for the industry

Medical Marketing and Media

Mon, 04/24/23 - 11:45 am

Finding the big spenders beyond big pharma

EP Vantage

Mon, 04/24/23 - 10:15 am

Gilead Sciences

Moderna Therapeutics

Regeneron Pharmaceuticals

Vertex Pharmaceuticals

Playing catch-up, Boehringer taps RetinAI for AI boost to eye disease R&D

Fierce Biotech

Fri, 04/21/23 - 10:14 am

Boehringer Ingelheim

artificial intelligence

geographic atrophy

Big pharma holds steady on research spending

EP Vantage

Fri, 04/21/23 - 10:03 am

Big pharma’s biggest spenders revealed: 2022 edition

EP Vantage

Fri, 04/21/23 - 10:00 am

Bristol Myers Squibb

Regeneron expects $56M IPR&D charge tied to cell therapy pact

Fierce Biotech

Mon, 04/10/23 - 04:53 pm

Sonoma Biotherapeutics

Layoffs loom as Takeda trims early-stage efforts in AAV gene therapy, rare hematology

Fierce Biotech

Fri, 04/7/23 - 01:45 pm

AbbVie knocks down earnings forecast due to IPR&D charge

Fierce Biotech

Thu, 04/6/23 - 11:54 am

Record growth in U.S. life sciences real estate footprint

Axios

Tue, 04/4/23 - 12:31 pm

Galapagos, following Sanofi’s playbook, offloads French R&D site to drug discovery CRO

Fierce Biotech

Fri, 03/31/23 - 10:27 am

'Stunning' 4% yearly rise in R&D share has emerging biopharma dominating pipeline

Fierce Biotech

Thu, 03/30/23 - 10:56 pm

emerging biopharma

Covant and Boehringer Ingelheim Collaborate to Develop a Novel ADAR1 Inhibitor for Use in Cancer Patients

Marketscreener

Tue, 03/28/23 - 10:20 am

Covant Therapeutics

Boehringer Ingelheim

Top 10 pharma R&D budgets in 2022

Fierce Biotech

Mon, 03/27/23 - 10:21 pm

Bristol Myers Squibb

PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects

CP Wire

Mon, 03/27/23 - 02:29 pm

PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects

Mon, 03/27/23 - 02:15 pm

‘Huge boost for biotech companies’: UK life sciences industry welcomes new enhanced R&D tax relief rate

Biopharma Reporter

Thu, 03/23/23 - 11:11 am

BeiGene Enters New Phase to Expand US Manufacturing and R&D Footprint

NJ Business

Wed, 03/22/23 - 11:12 am

drug manufacturing

Further shuffling at Leo Pharma as dermatology drugmaker splits R&D

Endpoints

Wed, 03/15/23 - 10:05 am

Bayer Plans to Double Down on US Pharma R&D in 2023

BioSpace

Thu, 03/9/23 - 10:07 am

Revamped Covid panel argues for research limits, even bans

Stat

Wed, 03/8/23 - 09:59 pm

federal government

Pages